Synergies between diabetes and hyperhomocysteinaemia: New insights to predict and prevent adverse cardiovascular effects
Fan X, Liu Y, Chen X, et al.
Diabetes Obes Metab. Pub. online 21 Oct 2024.
Leggi
The associations between functional vitamin K status and all-cause mortality, cardiovascular disease and end-stage kidney disease in persons with type 1 diabetes
Friis Bryde Nielsen C, Møller Thysen S, Bach Kampmann F, et al.
Diabetes Obes Metab. Pub. online 21 Oct 2024.
Leggi
National health and economic impact of a lifestyle program to prevent type 2 diabetes mellitus in Germany: a simulation study
Ogurtsova K, Laxy M, Emmert-Fees K, et al.
BMJ Open Diabetes Res Care. 2024;12(5):e004382.
Leggi
Graded association of muscle strength with all-cause and cause-specific mortality in older adults with diabetes: Prospective cohort study across 28 countries
Andersen LL, Calatayud J, Núñez-Cortés R, et al. Diabetes Obes Metab. Pub. online 23 Oct 2024. Abstract
Leggi
Body mass index trajectories and time in target range after delivery and long-term type 2 diabetes risk in women with a history of gestational diabetes mellitus
Zhang L, Shen Y, Liu H, et al.
Diabetes Obes Metab. Pub. online 21 Oct 2024.
Leggi
Cancellazione prestazione 95.09.1 esame del fundus nei nuovi LEA
Carissimi Soci, siamo a condividere la comunicazione istituzionale a firma AMD-AME-SID-SIE relativa alla recente cancellazione della prestazione 95.09.1 "esame del fundus” dai nuovi LEA. Visto il prevedibile impatto negativo sulla qualità dell’assistenza alle persone con diabete, AMD e SID sono state promotrici di questa istanza di modifica inviata all’Onorevole Giovanni…
Leggi
CARENZA DEI FARMACI GLP-1
Carissimi Soci, in riferimento alla precedente comunicazione inter-societaria in materia di carenza di farmaci GLP-1 condivisa il 18 settembre us, vi alleghiamo, a seguire, le risposte delle Aziende: Lettera Lilly Lettera Novo Nordisk In attesa di un riscontro formale anche da parte di AIFA, ci teniamo a precisare che il…
Leggi
Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92)
Lin B, Coleman RL, Bragg F, et al.
Lancet Diabetes Endocrinol. Pub. online 23 Oct 2024.
Leggi
Long-term effects of empagliflozin in patients with chronic kidney disease
Herrington WG, Staplin N, Agrawal N, et al. for EMPA-KIDNEY Collaborative Group N Engl J Med. Pub. online 25 Oct 2024. Abstract e full text
Leggi
Depression symptoms, wellbeing, health-related quality of life, and diabetes-related distress in novel subtypes of recent-onset diabetes in Germany: a 5-year observational follow-up study
Sommer J, Borgmann SO, Gontscharuk V, et al.
Lancet Diabetes Endocrinol. Pub. online 24 Oct 2024.
Leggi